Titan Pharmaceuticals
TTNP
#10996
Rank
A$9.24 M
Marketcap
A$6.95
Share price
-3.76%
Change (1 day)
13.65%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$7.1 Million, an increase over its 2023 earnings that were of -A$8.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-39.09%
2024 -A$7.1 Million-15.5%
2023 -A$8.4 Million-45.43%
2022 -A$15.4 Million16.29%
2021 -A$13.24 Million-907.36%
2020 A$1.63 M-106.6%
2019 -A$24.82 Million82.4%
2018 -A$13.61 Million-36.93%
2017 -A$21.58 Million-378.62%
2016 A$7.74 M-145.53%
2015 -A$17.01 Million369.37%
2014 -A$3.63 Million-125.9%
2013 A$13.99 M-177.74%
2012 -A$18 Million13.59%
2011 -A$15.85 Million74.37%
2010 -A$9.09 Million3.61%
2009 -A$8.77 Million
2007 -A$27.8 Million12.08%
2006 -A$24.81 Million-28.65%
2005 -A$34.77 Million-10.03%
2004 -A$38.64 Million-6.08%
2003 -A$41.14 Million-14.76%
2002 -A$48.27 Million32.52%
2001 -A$36.42 Million27.55%
2000 -A$28.56 Million62.5%
1999 -A$17.58 Million4.04%
1998 -A$16.89 Million49.33%
1997 -A$11.32 Million-27.88%
1996 -A$15.69 Million13.04%
1995 -A$13.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.23 B-667,515.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$19.06 B-450,830.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-A$0.27 Billion 6,242.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$46.26 M-1,193.69%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$16.21 Million 283.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.5 Billion 11,515.97%๐Ÿ‡บ๐Ÿ‡ธ USA